National Research Corporation

NRC

US6373722023

Business Support Services

Market Closed - Nasdaq Other stock markets 04:00:00 2025-06-20 pm EDT			5-day change	1st Jan Change
16.55 ^USD	-1.66%		+3.18%	-6.18%

Apr. 28	Tranche Update on National Research Corporation's Equity Buyback Plan announced on May 20, 2022.	CI
Apr. 28	National Research Corporation announces an Equity Buyback for 1,000,000 shares.	CI

National Research Corporation Announces Chief Executive Officer Changes

Published on 03/04/2025 at 16:01

National Research Corporation announced on February 26, 2025, that the board of directors of the Company appointed Trent Green as the Company?s Chief Executive Officer, effective June 1, 2025 (the Effective Date). Upon the effectiveness of Mr. Green?s appointment as Chief Executive Officer, Micheal D. Hays, the Company?s current Chief Executive Officer, will transition to the role of Chairman and Mr. Green will become the Company?s principal executive officer. Trent Green, 53, served as Chief Executive Officer of Amazon One Medical from September 2023 to February 2025 and as Chief Operating Officer from July 2022 through August 2023.

Prior to Amazon One Medical, Mr. Green served in various roles at Legacy Health, including Senior Vice President and Chief Operating Officer between 2019 and 2022, President between 2017 and 2019, and Senior Vice President and Chief Strategy Officer between 2008 and 2017. From 1999 to 2008, Mr. Green was a management consultant for Tiber Group/Navigant Consulting (now Guidehouse).

Latest news about National Research Corporation

Tranche Update on National Research Corporation's Equity Buyback Plan announced on May 20, 2022.	Apr. 28	CI
National Research Corporation announces an Equity Buyback for 1,000,000 shares.	Apr. 28	CI
National Research Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025	Apr. 28	CI
National Research Corporation authorizes a Buyback Plan.	Apr. 24	CI
National Research Corp - Michael D. Hays Designated As Principal Financial Officer	Apr. 22	RE
National Research Corporation Appoints Jordan N. Freeman as Chief Accounting Officer	Apr. 22	CI
National Research Corporation Appoints Michael D. Hays as Principal Financial Officer	Apr. 22	CI
National Research Corporation's Equity Buyback announced on May 20, 2022, has closed with 2,500,000 shares, representing 10.35% for $75.72 million.	Mar. 30	CI
National Research Appoints Trent Green as Chief Executive	Mar. 05	MT
National Research Corporation Appoints Trent Green as Chief Executive Officer	Mar. 04	RE
National Research Corporation Announces Management Changes	Mar. 04	CI
National Research Corporation Announces Chief Executive Officer Changes	Mar. 04	CI
Uofl Health Chooses NRC Health to Elevate Patient and Employee Experience Initiatives	Feb. 25	CI
National Research Lands $110 Million Delayed Draw-Down Term Facility; Shares Rise	Feb. 10	MT
National Research Corporation Enters into A Credit Agreement	Feb. 10	CI
Tranche Update on National Research Corporation's Equity Buyback Plan announced on May 20, 2022.	Jan. 27	CI
National Research Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024	Jan. 27	CI
NRC Health to Support Renown Health Patient Experience, Operational Efficiency	Jan. 07	MT
Renown Health Selects NRC Health as Partner to Enhance Patient Experience and Operational Efficiency	Jan. 07	CI
National Research Corporation(NasdaqGS:NRC) dropped from S&P Health Care Services Select Industry Index	Dec. 22	CI
Cooper University Health Care Selects NRC Health as New Patient Experience Partner	Nov. 12	CI
Earnings Flash (NRC) NATIONAL RESEARCH CORPORATION Posts Q3 Revenue $35.8M	24-10-25	MT
Tranche Update on National Research Corporation's Equity Buyback Plan announced on May 20, 2022.	24-10-25	CI
National Research Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	24-10-25	CI
National Research Corporation Appoints Helen L. Hrdy as Chief Operating Officer	24-10-15	CI

Chart National Research Corporation

Duration

Period

NRC: Dynamic Chart

Company Profile

National Research Corporation, doing business as NRC Health, is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare organizations in the United States. Its digital solutions consist of three primary solution categories: Marketing, Reputation and Experience. Its Marketing solutions are subscription-based services that allow for improved tracking of awareness, perception, and consistency of healthcare brands; real-time assessment of competitive differentiators, and enhanced segmentation tools to evaluate the needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. The Company's Experience solutions are provided on a subscription basis via a cross-continuum multi-mode digital platform. Its Reputation solutions allow healthcare organizations to share a picture of their organization.

Employees

368

Sector

Business Support Services

Calendar

Aug. 04 - Q2 2025 Earnings Release (Projected)

More about the company